Weight-loss drugs show promise in tackling opioid and alcohol abuse
Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use
Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use
Strong day for banking stocks lifts Irish market, while Airbnb and Puma fall after weak outlook statements
Danish company employs about 450 people in Ireland
Seen & Heard: Inheritance tax reduction, Press Up stake and Spar sale
Iseq index outperforms its peers, adding 1.5% after positive updates from Smurfit Kappa and Glenveagh Homes
Europe’s regulations have become ‘too burdensome’ and could hinder innovation, argues Michael Lohan
Continent’s top firms drove most of European equity gains last year
Pan-European Stoxx 600 extends gains and hit a fresh record high, rising 1 per cent
Drug maker trades on multiples unheard of in pharma sector over anticipated sales of weight loss drug
Stocktake: Europe’s most valuable company last week exceeded a market value of $500bn after reporting better-than-expected earnings
The drug maker has struggled to keep up with demand for both Wegovy and Ozempic
From flight cancellation misery and forfeited pay to corporation tax hauls and obesity drug bonanzas, everything in 2023 had either a value or a cost
News of new factory comes after Danish group announced in December the purchase of drug manufacturing plant in Athlone in order to keep up with demand for weight-loss drugs
Pharmaceutical giant suffers a post-Covid-19 hangover as demand for pandemic vaccines and medicines falls sharply
Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments
Proposals would lower time period a company has protection over research behind drugs they develop
Correspondence between health officials details 'high level of concern' about obesity drug shortages
Helge Lund has sought to reassure investors following Looney’s abrupt departure
Company boosted by trial results showing weight loss drug also cuts risk of heart attack by 20%
Planet Business: Pre-Swift concert film hits, Qantas’s under-fire chairman, and the ascent of Novo Nordisk
Novo Nordisk profits surging due to huge demand for obesity drugs Ozempic and Wegovy
Website advertising Ozempic for sale online falsely using address of north Dublin pharmacy
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
Sportswear companies among fallers after downbeat profit forecast from US retailer Foot Locker
Danish drugmaker pushing for US and EU approval but has struggled to meet demand for its Ozempic and Wegovy drugs
French luxury group’s share price rises as sector continues to benefit from China rebound
Demand for diabetes drug Ozempic, also used off label for weight loss, also fuels near doubling of sales and profit expectations
US shares fall on inflation worries
Iseq closes slightly higher with house builders Cairn and Glenveagh in focus
Travel stocks fell 1 per cent, but were above their intra-day lows touched earlier in session
Obesity drug resulted in weight loss of more than 10%, research shows
Fears about falling Chinese demand send iron ore prices plunging in London
Drugmaker, which spun out of Elan is selling PRX004 so it can focus on other therapies
Those who got the drug in a trial lost close to 15% of their body weight, compared with 2.4% among those receiving the placebo
Iseq lags European peers, but closes marginally ahead
Iseq fell 1.74% as banks take a hammering
Novo Nordisk wary of pandemic’s impact on patient diagnosis and ability to pay
But Tesla and Airbus among the companies to fall on concerns about China outbreak
Netflix takes a battering as analysts queries international subscriber growth
Test flight is first time the technology has been used in management of diabetes
Iseq performed in line with European peers, rose 0.34%
Drug failure pushes pharma giant to lower forecasts for 2019
Good day for Irish shares with Iseq overall index rising 1.08%
Investors both sides of the Atlantic take a cautiously optimistic view of US-China talks
Fountain Healthcare participates in €17m funding round for Syndesi Therapeutics
Total Produce climbs 6.4% on foot of its €242 million deal to buy a stake in Dole Food Company
Food industry stocks weak in Dublin as overall volumes are below average
Paddy Power Betfair falls by almost 0.7 per cent on chief executive Peter Jackson’s first day in the job
Board said offer ‘fundamentally undervalues’ Ablynx and its prospects
Study, which took more than a decade, involved 1.8 million Danish women
Dublin closes lower, with Permanent TSB and Smurfit among the weakest stocks
Pharma giant facing into expiry of key patents and investors are becoming itchy
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices